CDC weighs risk of BA.2.86 COVID-19 lineage

CDC weighs risk of BA.2.86 COVID-19 lineage

The US Centers for Disease Control and Prevention (CDC) issued its initial risk assessment of the BA.2.86 SARS-CoV-2 lineage, which says tests and treatments will likely be effective and that updated vaccines will still be able to reduce severe disease and...
COVID-19 vax lowers severity, mortality post infection

COVID-19 vax lowers severity, mortality post infection

In one of the largest studies of its kind, researchers provide answers to whether COVID-19 vaccinations reduce sickness and mortality following infection with SARS-CoV-2. The study published in The Lancet Microbe found among individuals recently infected with...
Bivalent COVID booster better than 1-strain 4th dose

Bivalent COVID booster better than 1-strain 4th dose

CREDIT: NIH/NIAID cc A fourth dose of the bivalent (two-strain) COVID-19 vaccine is substantially more effective against medical treatment and hospitalization than a fourth monovalent (single-strain) dose among both previously infected and never-infected people who...
CDC to provide free COVID-19 vaccines to adults

CDC to provide free COVID-19 vaccines to adults

To help ensure that millions of uninsured and underinsured American adults continue to have access to no-cost COVID-19 vaccinations, the Centers for Disease Control and Prevention (CDC) is launching the Bridge Access Program for COVID-19 Vaccines this fall. There are...
COVID vaccine may boost MERS, coronavirus antibodies

COVID vaccine may boost MERS, coronavirus antibodies

Colorized scanning electron micrograph of Middle East Respiratory Syndrome virus particles (yellow) attached to the surface of an infected VERO E6 cell (blue). CREDIT: NIAID/NIH A small Qatar University–led study published in JAMA Network Open suggests that COVID-19...